An acute increase in skeletal muscle carnitine content alters fuel metabolism in resting human skeletal muscle

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 12, 2006, Pages 5013-5018

  Stephens, Francis B ^a,b   Constantin Teodosiu, Dumitru ^a   Laithwaite, David ^a   Simpson, Elizabeth J ^a   Greenhaff, Paul L ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; CARNITINE; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLYCOGEN; INSULIN; LACTIC ACID; PYRUVATE DEHYDROGENASE COMPLEX; SODIUM CHLORIDE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID COMPOSITION; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; GLYCOGEN MUSCLE LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; MUSCLE BIOPSY; MUSCLE METABOLISM; NORMAL HUMAN; OUTCOME ASSESSMENT; OXIDATION; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 33845482289     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1584     Document Type: Article

References (40)

1. Brass EP 1995 Pharmacokinetic considerations for the therapeutic use of carnitine in haemodialysis patients. Clin Ther 17:176-185
2. Fritz IB, McEwen B 1959 Effects of carnitine on fatty-acid oxidation by muscle. Science 129:334-335
3. Fritz IB, Yue KTN 1963 Long-chain carnitine acyltransferase and the role of acylcarnitine derivatives in the catalytic increase of fatty acid oxidation induced by carnitine. J Lipid Res 4:279-288
4. Childress CC, Sacktor B 1966 Pyruvate oxidation and the permeability of mitochondria from blowfly flight muscle. Science 154:268-270
5. Harris RC, Foster CV, Hultman E 1987 Acetylcarnitine formation during intense muscular contraction in humans. J Appl Physiol 63:440-442
6. Constantin-Teodosiu D, Carlin JI, Cederblad G, Harris RC, Hultman E 1991 Acetyl group accumulation and pyruvate dehydrogenase activity in human muscle during incremental exercise. Acta Physiol Scand 143:367-372
7. van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ 2001 The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 536:295-304
8. Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JF, Richter EA, Kiens B 2005 Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol 288:E133-E142
9. Muller DM, Seim H, Kiess W, Loster H, Richter T 2002 Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism 51:1389-1391
10. Wutzke KD, Lorenz H 2004 The effect of L-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects. Metabolism 53:1002-1006
11. Brass EP 2000 Supplemental carnitine and exercise. Am J Clin Nutr 72:618S-623S
12. Wächter S, Vogt M, Kreis R, Boesch C, Bigler P, Hoppeler H, Krähenbühl S 2002 Long-term administration of L-carnitine to humans: effect on skeletal muscle carnitine content and physical performance. Clin Chim Acta 318:51-61
13. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL 2006 Insulin stimulates L-carnitine accumulation in human skeletal muscle. FASEB J 20:377-379
14. Martin IK, Katz A, Wahren J 1995 Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol 269:E583-E590
15. Blaak EE 2004 Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc 63:323-330
16. Kelley DE, Simoneau J 1994 Impaired free fatty acid utilization by skeletal muscle in non-insulin dependent diabetes mellitus. J Clin Invest 94:2349-2356
17. Colberg SR, Simoneau JA, Thaete FL, Kelley DE 1995 Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95:1846-1853
18. Kelley DE, Goodpaster BH, Wing RR, Simoneau JA 1999 Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130-E1141
19. Blaak EE, Wagenmakers AJM, Glatz JFC, Wolffenbuttel BHR, Kemerink GJ, Langenberg CJM, Heidendal GAK, Saris WH 2000 Plasma free fatty acid utilization and fatty acid binding protein content are diminished in forearm skeletal muscle of type 2 diabetic subjects. Am J Physiol 279:E146-E154
20. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA 2000 Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49:2102-2107
21. Gallen IW, Macdonald IA 1990 Effect of two methods of hand heating on body temperature, forearm blood flow, and deep venous oxygen saturation. Am J Physiol 259:E639-E643
22. DeFronzo RA, Tobin J, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
23. Cederblad G, Finnstrom O, Martensson J 1982 Urinary excretion of carnitine and its derivatives in newborns. Biochem Med 27:260-265
24. Bergström J 1975 Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35:609-616
25. Cederblad G, Carlin JI, Constantin-Teodosiu D, Harper P, Hultman E 1990 Radioisotopic assays of CoASH and carnitine and their acetylated forms in human skeletal muscle. Anal Biochem 185:274-278
26. Harris RC, Hultman E, Nordesjo LO 1974 Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest: methods and variance values. Scand J Clin Lab Invest 33:109-120
27. Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del Chiaro D, Oleggini M, Brandi L, Maccari F 1988 Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 255:E946-E952
28. Angelini A, Imparato L, Landi C, Porfido FA, Ciarimboli M, Marro A 1993 Variation in levels of glycaemia and insulin after infusion of glucose solutions with or without added L-carnitine. Drugs Exp Clin Res 19:219-222
29. Negro P, Gossetti F, La Pinta M, Mariani P, Carboni M 1994 The effect of L-carnitine, administered through intravenous infusion of glucose, on both glucose and insulin levels in healthy subjects. Drugs Exp Clin Res 20:257-262
30. Randle PJ, Garland PJ, Hales CJ, Newsholme EJ 1963 The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789
31. Randle PJ, Newsholme EJ, Garland PJ 1964 Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 93:652-665
32. Garland PB, Randle PJ 1963 Effects of alloxan diabetes and adrenaline on concentrations of free fatty acids in rat heart and diaphragm muscles. Nature 199:381-382
33. Garland PB, Randle PJ, Newsholme EA 1963 Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes, and starvation. Nature 200:169-170
34. McGarry JD, Mills SE, Long CS, Foster DW 1983 Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues: demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214:21-28
35. Oakes ND, Bell KS, Furler SM 1997 Diet induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes 46:2022-2028
36. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E 2002 Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51:144-151
37. Hegarty BD, Furler SM, Yee AJ, Cooney GJ, Kraegen GW 2003 The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178:373-383
38. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, Houmard JA 2003 Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284:E741-E747
39. Schalin-Jantti C, Harkonen M, Groop LC 1992 Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41:598-604
40. Jensen J, Jebens E, Brennesvik EO, Ruzzin J, Soos MA, Engebretsen EM, O'Rahilly S, Whitehead JP 2006 Muscle glycogen inharmoniously regulates glycogen synthase activity, glucose uptake, and proximal insulin signalling. Am J Physiol Endocrinol Metab 290:E154-E162